Co-Diagnostics (CODX) Set to Announce Quarterly Earnings on Thursday

Co-Diagnostics (NASDAQ:CODX) is set to issue its quarterly earnings data after the market closes on Thursday, May 9th. Analysts expect the company to announce earnings of ($0.21) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Co-Diagnostics (NASDAQ:CODX) last posted its quarterly earnings data on Thursday, March 14th. The company reported ($0.50) earnings per share (EPS) for the quarter. Co-Diagnostics had a negative net margin of 518.69% and a negative return on equity of 35.37%. The business had revenue of $3.56 million for the quarter, compared to analysts’ expectations of $3.63 million.

Co-Diagnostics Stock Up 2.6 %

CODX stock opened at $1.19 on Thursday. Co-Diagnostics has a twelve month low of $0.98 and a twelve month high of $1.89. The firm has a market cap of $37.20 million, a price-to-earnings ratio of -0.96 and a beta of -0.68. The business’s fifty day simple moving average is $1.15 and its two-hundred day simple moving average is $1.20.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reduced their price target on shares of Co-Diagnostics from $3.00 to $2.50 and set a “neutral” rating on the stock in a research note on Friday, March 15th.

About Co-Diagnostics

Co-Diagnostics, Inc, a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting.